Literature DB >> 15004795

In vivo assessment of tumoral angiogenesis.

I Troprès1, L Lamalle, M Péoc'h, R Farion, Y Usson, M Décorps, C Rémy.   

Abstract

Vessel size imaging (VSI) for brain tumor characterization was evaluated and the vessel size index measured by MRI (VSIMRI) was correlated with VSI obtained by histology (VSIhisto). Blood volume (BV) and VSI maps were obtained on 12 rats by simultaneous measurements of R2* and R2, before and after the injection of a macromolecular contrast agent, AMI-227. Immunostaining of collagen IV in vessels was performed. An expression was derived for evaluating VSI from stereologic measurements on histology data (VSIhisto). On BV and VSI images obtained from large-size tumors (n = 9), three regions could be distinguished and correlated well with histological sections: a high BV region surrounding the tumor, a necrotic area where BV is very low, and a viable tumor tissue region showing lower BV but higher VSI than the normal rat cortex, with the presence of larger vessels. The quantitative analysis showed a good correlation (Spearman rank's rho = 0.74) between VSIhisto and VSIMRI with a linear regression coefficient of 1.17. The good correlation coefficient supports VSI imaging as a quantitative method for tumor vasculature characterization. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004795     DOI: 10.1002/mrm.20017

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  44 in total

1.  Is T2* enough to assess oxygenation? Quantitative blood oxygen level-dependent analysis in brain tumor.

Authors:  Thomas Christen; Benjamin Lemasson; Nicolas Pannetier; Regine Farion; Chantal Remy; Greg Zaharchuk; Emmanuel L Barbier
Journal:  Radiology       Date:  2011-12-09       Impact factor: 11.105

2.  How stereological analysis of vascular morphology can quantify the blood volume fraction as a marker for tumor vasculature: comparison with magnetic resonance imaging.

Authors:  Adriana T Perles-Barbacaru; Boudewijn P J van der Sanden; Regine Farion; Hana Lahrech
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-09       Impact factor: 6.200

3.  Vessel size imaging using low intravascular contrast agent concentrations.

Authors:  I Troprès; L Lamalle; R Farion; C Segebarth; C Rémy
Journal:  MAGMA       Date:  2004-12-01       Impact factor: 2.310

4.  Clinical translation of ferumoxytol-based vessel size imaging (VSI): Feasibility in a phase I oncology clinical trial population.

Authors:  Jill Fredrickson; Natalie J Serkova; Shelby K Wyatt; Richard A D Carano; Andrea Pirzkall; Ina Rhee; Lee S Rosen; Alberto Bessudo; Colin Weekes; Alex de Crespigny
Journal:  Magn Reson Med       Date:  2016-02-26       Impact factor: 4.668

5.  Longitudinal in vivo monitoring of rodent glioma models through thinned skull using laser speckle contrast imaging.

Authors:  Abhishek Rege; Alan C Seifert; Dan Schlattman; Yu Ouyang; Khan W Li; Luca Basaldella; Henry Brem; Betty M Tyler; Nitish V Thakor
Journal:  J Biomed Opt       Date:  2012-12       Impact factor: 3.170

6.  Dispersion of relaxation rates in the rotating frame under the action of spin-locking pulses and diffusion in inhomogeneous magnetic fields.

Authors:  John T Spear; Zhongliang Zu; John C Gore
Journal:  Magn Reson Med       Date:  2013-06-26       Impact factor: 4.668

Review 7.  Translational MR Neuroimaging of Stroke and Recovery.

Authors:  Emiri T Mandeville; Cenk Ayata; Yi Zheng; Joseph B Mandeville
Journal:  Transl Stroke Res       Date:  2016-08-31       Impact factor: 6.829

8.  Longitudinal studies of angiogenesis in hormone-dependent Shionogi tumors.

Authors:  Trevor P Wade; Piotr Kozlowski
Journal:  Neoplasia       Date:  2007-07       Impact factor: 5.715

9.  Monitoring the Vascular Response and Resistance to Sunitinib in Renal Cell Carcinoma In Vivo with Susceptibility Contrast MRI.

Authors:  Simon P Robinson; Jessica K R Boult; Naveen S Vasudev; Andrew R Reynolds
Journal:  Cancer Res       Date:  2017-05-31       Impact factor: 12.701

10.  GESFIDE-PROPELLER approach for simultaneous R2 and R2* measurements in the abdomen.

Authors:  Ning Jin; Yang Guo; Zhuoli Zhang; Longjiang Zhang; Guangming Lu; Andrew C Larson
Journal:  Magn Reson Imaging       Date:  2013-09-14       Impact factor: 2.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.